IMU 9.26% 5.9¢ imugene limited

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-131

  1. 560 Posts.
    lightbulb Created with Sketch. 255
    Last years effort for those interested might stop the riff raff, this article was received by AACR Sept 27 2022, revised Jan 25th 2023, Accepted May 15th 2023 published in their Journal July 2023. it takes time, these are very prestigious events that cover a multitude of cancers, treatments, studies, research, break through's etc. to think IMU has the holy grail and will cure all cancer is a wee bit premature.

    If vaxinia or a variant proves to be more effaces in some types of cancer than the current standard of care I'll be happy share price should appreciate but to think someone is going to stand on a soap box and say we've got the cure for cancer is too much of a stretch. Calm the farm.


    An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model | Molecular Cancer Therapeutics | American Association for Cancer Research (aacrjournals.org)

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.